陈希瑶, 张富洋. 心力衰竭易损期的定义与药物治疗[J]. 心脏杂志, 2022, 34(3): 348-351. DOI: 10.12125/j.chj.202103061
    引用本文: 陈希瑶, 张富洋. 心力衰竭易损期的定义与药物治疗[J]. 心脏杂志, 2022, 34(3): 348-351. DOI: 10.12125/j.chj.202103061
    Xi-yao CHEN, Fu-yang ZHANG. Progress in definition and management of vulnerable phase after hospitalization for heart failure.[J]. Chinese Heart Journal, 2022, 34(3): 348-351. DOI: 10.12125/j.chj.202103061
    Citation: Xi-yao CHEN, Fu-yang ZHANG. Progress in definition and management of vulnerable phase after hospitalization for heart failure.[J]. Chinese Heart Journal, 2022, 34(3): 348-351. DOI: 10.12125/j.chj.202103061

    心力衰竭易损期的定义与药物治疗

    Progress in definition and management of vulnerable phase after hospitalization for heart failure.

    • 摘要: 心力衰竭(HF)是多种心血管疾病发展到终末阶段的一种临床综合症,致死率和致残率高。急性HF患者接受住院治疗症状好转并出院后的(2~3)个月内,因HF恶化再次入院和死亡的风险很高,这个时期被称为HF易损期。HF易损期处于急性失代偿HF向慢性稳定性HF转变的衔接阶段。因此,优化HF易损期的监测和治疗对于改善HF患者预后非常关键。本文就HF易损期的定义、病理生理机制、临床特征和药物治疗作一总结。

       

      Abstract: Heart failure (HF) is a clinical syndrome with high mortality and morbidity rate. The risk of readmission and death of patients with acute HF is extremely high within 2-3 months after they are discharged from the hospital. This period is termed as the vulnerable phase after hospitalization for HF. The vulnerable phase of HF is the transition stage from acute decompensated HF to chronic stable HF. Thus, optimizing the monitoring and the treatment during the vulnerable phase is very important to improve the prognosis of HF patients. The present article reviews the definition, pathophysiological mechanisms, clinical features and therapies of the vulnerable phase after hospitalization for HF.

       

    /

    返回文章
    返回